91Ó°ÊÓ

Natural killer cells, commonly known as NK cells, are a critical component of the innate immune system. These cells have the unique ability to recognize and attack cells that do not display normal MHC I (Major Histocompatibility Complex Class I) molecules on their surface. This ability allows NK cells to target virus-infected cells and certain tumor cells. Their role is crucial because they do not require prior sensitization to a specific antigen to exert their effects.
They achieve this by using a repertoire of receptors to detect stress signals or changes in MHC I expression on target cells. When NK cells identify a cell lacking proper MHC I molecules, they release cytotoxic granules containing perforin and granzymes. These substances induce apoptosis (cell death) in the target cell.
By patrolling the body, NK cells serve as a rapid first line of defense against abnormal cells, contributing to surveillance and maintenance of healthy tissues.

The immune response is the body's defense mechanism against foreign invaders such as viruses, bacteria, and transplanted tissues. It involves a coordinated effort between various types of immune cells and molecules. There are two primary types of immune responses: innate and adaptive immunity.
The innate immune response provides immediate, non-specific defenses against infection. It includes physical barriers like the skin, phagocytic cells (e.g., macrophages and neutrophils), and NK cells. It also involves inflammatory responses and chemical defenses like antimicrobial peptides.
The adaptive immune response, on the other hand, is highly specific and involves the activation of lymphocytes (B cells and T cells) that recognize specific antigens. This response generates immunological memory, providing long-lasting protection against previously encountered pathogens. The immune system's ability to differentiate self from non-self is crucial for preventing attacks on the body's own tissues.

Transplant immunology studies the immune responses involved in the acceptance or rejection of transplanted organs and tissues. A key challenge in transplantation is avoiding immune rejection, where the recipient's immune system recognizes the transplanted organ as foreign and attacks it.
The immune system primarily identifies transplanted tissues as foreign through differences in MHC I molecules between the donor and recipient. MHC I molecules present peptide fragments on cell surfaces, and any variation in these molecules can trigger an immune response. NK cells, T cells, and other immune cells play a pivotal role in mediating this response.
To prevent rejection, transplant patients often undergo immunosuppressive therapy, which dampens the immune system's activity. Careful matching of donor and recipient MHC molecules through tissue typing also helps in reducing the likelihood of rejection. However, even with these precautions, complete immunological compatibility is challenging to achieve.

MHC I recognition is a crucial process that allows immune cells to monitor cellular health and detect abnormalities. MHC I molecules are present on all nucleated cells and display peptide fragments derived from intracellular proteins. This presentation allows immune cells, particularly cytotoxic T cells and NK cells, to inspect the presented peptides and identify any signs of infection or malignancy.
Cytotoxic T cells rely on their T-cell receptors (TCRs) to bind to specific peptide-MHC I complexes. If the peptide presented is foreign or abnormal, the T cell will initiate an attack on the presenting cell. NK cells, however, use a different mechanism. They assess the presence or absence of MHC I molecules. Cells lacking MHC I are considered unhealthy or foreign, and NK cells will target them for destruction.
The ability of immune cells to recognize and respond to MHC I molecules ensures that infected or cancerous cells are promptly eliminated, preserving the body's health. This process is also integral in the context of organ transplantation, where mismatched MHC I can lead to organ rejection.